Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 875 of 3546 entries
View as:

Bioequivalence Study of Escitalopram Tablets 10 mg

Phase: N/A Priority: Normal
NCT ID: NCT01745601 Org: User:
Start: 05/04/10 End: 05/19/10 Due: 05/19/11

A Phase III Parallel Group Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination (FDC) of Fluticasone Furoate+Umeclidinium Bromide+Vilanterol (FF/UMEC/VI) With the FDC of FF/VI in Subjects With Inadequately Controlled Asthma

Phase: N/A Priority: Normal
NCT ID: NCT02924688 Org: User:
Start: 10/13/16 End: 02/22/19 Due: 02/22/20

A First Time in Human Study of GSK586529 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00703547 Org: User:
Start: 01/28/08 End: 04/11/08 Due: 04/11/09

Study to Evaluate the Pharmacokinetics and Safety of GSK2336805 in Subjects With Hepatic Impairment and Healthy Matched Control Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01827657 Org: User:
Start: 05/28/13 End: 03/20/14 Due: 03/20/15

Pharmacokinetic and Pharmacodynamic (PK and PD) Study of Fluticasone Propionate and Salmeterol Combination Product Delivered in a Capsule-based Inhaler and in a Multi-dose Dry Powder Inhaler in Moderate Asthma Patients and Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Patients.

Phase: N/A Priority: Normal
NCT ID: NCT01494610 Org: User:
Start: 10/25/10 End: 06/08/11 Due: 06/08/12

Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK2126458 and GSK1120212 Combination Therapy in Subjects With Advanced Solid Tumors.

Phase: N/A Priority: Normal
NCT ID: NCT01248858 Org: User:
Start: 12/03/10 End: 04/23/15 Due: 04/23/16

A Randomized, Single Blind, Placebo Controlled Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single Oral Doses and Repeat Escalating Oral Doses of GSK2251052 in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01262885 Org: User:
Start: 10/07/10 End: 08/25/11 Due: 08/25/12

A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib

Phase: N/A Priority: Normal
NCT ID: NCT00996762 Org: User:
Start: 11/12/09 End: 09/18/12 Due: 09/18/13

Immunogenicity and Safety of DTPa-HBV-IPV/Hib Compared to DTPa-IPV/Hib and HBV Administered Concomitantly

Phase: N/A Priority: Normal
NCT ID: NCT01457495 Org: User:
Start: 09/30/98 End: 09/30/99 Due: 09/30/00

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effect of GSK2646264 in Cutaneous Lupus Erythematosus Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02927457 Org: User:
Start: 01/13/17 End: 06/12/18 Due: 06/12/19

Single Dose Study Of GW856553 On A Protein That Is An Indicator For Rheumatoid Arthritis (RA)

Phase: N/A Priority: Normal
NCT ID: NCT00256919 Org: User:
Start: 11/30/05 End: 11/30/06 Due: 11/30/07

KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks

Phase: N/A Priority: Normal
NCT ID: NCT00085943 Org: User:
Start: 05/31/04 End: - Due: -

A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Anticancer Activity of GSK4524101 Alone or With Niraparib in Participants With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06077877 Org: User:
Start: 10/24/23 End: 06/29/27 Due: 06/29/28

Serological Response to Porcine Circovirus Type 1 (PCV-1) and PCV-1 DNA in Stools of Infants Following Administration of Rotarix™

Phase: N/A Priority: Normal
NCT ID: NCT01511133 Org: User:
Start: 04/30/10 End: 06/30/10 Due: 06/30/11

To Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants in Co-administration With Specific Childhood Vaccines

Phase: N/A Priority: Normal
NCT ID: NCT00140686 Org: User:
Start: 09/30/04 End: 08/31/06 Due: 08/31/07

Evaluation of Food Effect on the Pharmacokinetics of Sustained Release Metformin in Healthy Indian Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01561976 Org: User:
Start: 01/30/12 End: 02/21/12 Due: 02/21/13

A Study of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Diphtheria, Pertussis and Tetanus (Tdap) Viruses Followed by a 2nd Dose of the RSV Vaccine to Healthy Non-Pregnant Women

Phase: N/A Priority: Normal
NCT ID: NCT04138056 Org: User:
Start: 11/05/19 End: 11/22/21 Due: 11/22/22

Efficacy and Safety of Depemokimab (GSK3511294) in Participants With Chronic Rhinosinusitis With Nasal Polyps (ANCHOR-2)

Phase: N/A Priority: Normal
NCT ID: NCT05281523 Org: User:
Start: 04/18/22 End: 08/06/24 Due: 08/06/25

Effect Of GW501516X On How The Heart Obtains And Uses Energy

Phase: N/A Priority: Normal
NCT ID: NCT00318617 Org: User:
Start: 12/31/05 End: - Due: -

Incidence of Expression of Tumor Antigens in Cancer Tissue From Patients With Pathologically Demonstrated Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01706185 Org: User:
Start: 01/15/08 End: 01/15/08 Due: 01/15/09

12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00373542 Org: User:
Start: 10/31/06 End: 06/30/07 Due: 06/30/08

To Assess the Excretion Balance and Pharmacokinetics of a Single Oral Dose of [14C]GW856553 in Healthy Adult Males

Phase: N/A Priority: Normal
NCT ID: NCT00599612 Org: User:
Start: 01/17/08 End: 02/18/08 Due: 02/18/09

Out-Patient Study in Patients With Type 2 Diabetes Mellitus Who Are Taking no Diabetes Medication or Metformin Only

Phase: N/A Priority: Normal
NCT ID: NCT00518115 Org: User:
Start: 04/30/07 End: 05/31/08 Due: 05/31/09

A First Time in Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2798745 in Healthy Subjects and Stable Heart Failure Patients

Phase: N/A Priority: Normal
NCT ID: NCT02119260 Org: User:
Start: 06/09/14 End: 12/25/16 Due: 12/25/17

Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00428090 Org: User:
Start: 02/27/07 End: 09/05/08 Due: 09/05/09